Aim-To investigate the eYcacy of nasal high frequency ventilation (nHFV) in newborn infants with moderate respiratory insuYciency. Method-Twenty one preterm and term neonates were treated with nHFV for respiratory insuYciency. Criteria for starting nHFV were: deterioration on nasal CPAP expressed by a median pH of 7.24 and pCO 2 of 8.3 kPa, or increasing FIO 2 . nHFV was delivered using the Infant Star ventilator. Ventilator setting amplitude was 35 cm H 2 O; mean airway pressure 7 cm H 2 O; and frequency 10 Hz. Results-pCO 2 decreased significantly from 8.3 kPa to 7.2 kPa after nHFV was started. In five patients nHFV was discontinued after a median period of 6 1 ⁄2 hours due to CO 2 retention and high oxygen need, and endotracheal mechanical ventilation was started. Conclusions-nHFV can reduce pCO 2 in neonates with moderate respiratory insufficiency and, therefore, could be used to decrease the need for endotracheal mechanical ventilation. (Arch Dis Child Fetal Neonatal Ed 1998;79:F61-F63) Keywords: nasal high frequency ventilation; idiopathic respiratory distress syndrome Over the past two decades assisted mechanical ventilation has been used to manage respiratory insuYciency in newborn infants. However, complications such as airleaks occur in 15 to 48% of the infants who need ventilator support, 1 2 and 5 to 25% develop bronchopulmonary dysplasia (BPD).
Over the past two decades assisted mechanical ventilation has been used to manage respiratory insuYciency in newborn infants. However, complications such as airleaks occur in 15 to 48% of the infants who need ventilator support, 1 2 and 5 to 25% develop bronchopulmonary dysplasia (BPD). 3 Both these complications contribute substantially to morbidity in preterm infants. Therefore, a less invasive approach such as nasal continuous positive airway pressure (nCPAP) is frequently used in the initial management of respiratory insuYciency. [4] [5] [6] But 43 to 80% of the neonates with moderate to severe respiratory insuYciency, initially treated with nasal CPAP, will need subsequent mechanical ventilation. 7 Nasal CPAP has also been used after extubation to facilitate weaning from mechanical ventilation. [8] [9] [10] [11] However, extubation failed in 16 to 40% of cases. In both events subsequent endotracheal mechanical ventilation was needed because of CO 2 retention or increased oxygen need and apnoea of prematurity.
High frequency ventilation (HFV) is a new method of mechanical ventilation based on the delivery of small tidal volumes at a supraphysiological respiratory frequency of 10 Hz. 12 13 This technique is very eVective in eliminating carbon dioxide and is independent of dead space.
We hypothesised that HFV applied on a single nasopharyngeal tube (nHFV) might reduce pCO 2 by augmenting CO 2 diVusion in the pharynx and larynx area and, therefore, decreasing the need for subsequent mechanical ventilation. To test this hypothesis we performed a non-controlled observational study and tested the eYcacy of nHFV in infants with moderate respiratory insuYciency.
Methods
Twenty one newborn infants were oVered nHFV. All patients were initially treated with nasal CPAP applied via a single nasopharyngeal tube positioned at a depth of 3-4 cm. nHFV was started due to CO 2 retention (median value 8.3 kPa), acidosis (median pH value 7.24), and/or increasing oxygen need (median FIO 2 0.42) during nasal CPAP. We applied nHFV via the same nasopharyngeal tube by switching the ventilator (Infant Star HFV, Infrasonics, Inc. San Diego, CA, USA) to the HFV mode. This ventilator delivers HFV by flow interruption. NHFV was initiated with the following parameters: mean airway pressure (Pāw) was maintained or increased to a higher level; frequency of 10 Hz and amplitude was increased until the infant's chest showed oscillations; FIO 2 was regulated to achieve a peripheral oxygen saturation monitored by pulse oximetry of 86-93%. [14] [15] Arterial or capillary blood gases and ventilator settings were registered at a median time of 4] hours (3.28-6.25 hours) and of 0.57 hours (0.34-1.57 hours) before and 1 1 ⁄2 hours (0.50-2 hours), 4.24 hours (3.20-5.20 hours), 7.38 hours (6.52-8 hours), and 11 hours (10-13 hours) after nHFV initiation. Endotracheal mechanical ventilation was considered when blood gases further deteriorated: pH < 7.20; pCO 2 > 8.5 kPa; and FIO 2 > 0.80 or apnoea.
All values are reported as median with 20th and 80th percentiles. A Wilcoxon signed rank sum test for paired data was used to estimate statistical diVerence for blood gases and ventilator settings. DiVerences were considered statistical significant when p < 0.05.
Results
Twenty one patients were treated with nHFV. Table 1 summarises the clinical data. In five (23%) patients, nHFV was discontinued after a median time of 6 1 ⁄2 hours (2-8 1 ⁄2 hours), and endotracheal mechanical ventilation was started. Table 2 shows blood gas values and ventilator settings before and after initiating nHFV. NHFV was started in 16 infants because of CO 2 retention (pCO 2 value > 7.5 kPa) and in five infants because of increasing oxygen need (FIO 2 > 0.55). A small but significant reduction in pCO 2 was found (p = 0.0012; p = 0.0033) after initiation of nHFV compared with the two last blood gases taken before nHFV (figs 1 and 2). Pāw pressure was significantly higher after the initiation of nHFV.
In 15/21 (72%) patients, nHFV was initiated early in the course of their respiratory disease (median age of 17 hours; 2-36). Respiratory insuYciency was due to idiopathic respiratory distress syndrome (n =10), transient tachypnoea of the newborn (TTN) (n = 3), and hypoventilation (n = 2). NHFV was continued for a median (range) period of 35 (2-144) hours. In three patients with severe idiopathic RDS, nHFV was discontinued and endotracheal mechanical ventilation with surfactant replacement was started within 2 to 6 hours because of further deterioration in blood gases or increased oxygen need.
In 6/21 (28%) patients, nHFV was initiated at a median age 9 days (6-21), after a period of endotracheal mechanical ventilation. The diagnoses included air leak syndrome (n = 2) and apnoea associated with sepsis or necrotising enterocolitis (n = 4). NHFV in this group was continued for a median period of 40 hours . In two patients in this group with apnoea and sepsis, nHFV was discontinued and endotracheal mechanical ventilation was started because of further deterioration in blood gases and apnoea.
Discussion
This study has shown that nHFV can reduce pCO 2 in patients with nasal CPAP with diVerent respiratory problems. Whether nHFV can be recommended as a valuable mode of respiratory support must be determined in a prospective randomised study. We showed that nHFV was eVective in reducing pCO 2 from 8.3 kPa to 7.2 kPa within 2 hours.
The mechanism of CO 2 reduction during HFV is complex and is not completely understood. 13 16 As oscillations of the chest are 
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van der Hoeven, Brouwer, Blanco visible during nHFV, direct ventilation of the lung is less important; the larynges are a significant factor in resistance. 17 Gas transport during nHFV is probably largely improved by the interaction of convective and diVusive gas flux (also called augmented diVusion) in the pharyngeal and laryngeal area, as has been reported during HFV in the larger and medium airways. 16 18 Nasal CPAP has been proposed as a less invasive approach for the management of respiratory distress in very low birthweight infants. [4] [5] [6] After the introduction of nasal CPAP, a significant decrease in the incidence of intubation was reported. 19 Another report showed that the incidence of BPD was decreased in association with the use of early nasal CPAP and permissive hypercapnia. 20 However, the use of nasal CPAP seemed to be limited to a small group of infants, as 43 to 80% of the infants with moderate to severe idiopathic RDS went on to require mechanical ventilation due to CO 2 retention, increased oxygen need, and apnoea of prematurity. 7 The level of CPAP pressure is associated with an increase in paO 2 , indicating an increased functional residual capacity and/or alveolar recruitment. [21] [22] But high CPAP pressure was also associated with an increase in paCO 2 due to an increase in dead space, alveolar overdistension, and a decrease in alveolar ventilation. [21] [22] [23] nHFV could be used to control CO 2 retention and to permit the use of a higher Pāw pressure so as to reduce oxygen need.
Gaseous distension of the bowel has been mentioned as a disadvantage of the use of nasal CPAP in premature infants. This so-called CPAP belly syndrome has not been associated with necrotising enterocolitis or bowel obstruction and had a benign development. 24 In our study some infants who were breathing room air still had clinically significant CO 2 retention. In the alveolar air equation alveolar pO 2 is determined by the inspiratory oxygen concentration minus the alveolar pCO 2 , divided by the respiratory exchange ratio. When an alveolar pCO 2 is increased to, for example, 10 kPa and the infant is breathing room air and has a respiratory exchange ratio of 0.8, the alveolar pO 2 will be 8.5 kPa. Assuming that the gradient between alveolar and arterial pO 2 is not severely increased by atelectasis, scatter of ventilation perfusion ratios, or by the presence of a right to left shunt, a clinically significant hypercapnia can exist in association with a low but still normal and acceptable arterial pO 2 . In addition, as the P90 (the paO 2 required for 90% oxygen saturation of haemoglobin) in preterm infants was reported to be 5.4 (0.5) kPa, 25 there is no clinical or physiological basis to increase the PO 2 value when almost all haemoglobin is bound with oxygen.
In a heterogeneous group of infants with moderate respiratory diseases, nHFV was eVective in reducing pCO 2 . nHFV might, therefore, be a valuable addition to the ventilatory management of the newborn infant, and might reduce the need for subsequent mechanical ventilation.
